For over three decades, a highly accurate early diagnostic test for ovarian cancer has eluded physicians. Now, scientists in the Georgia Tech Integrated Cancer Research Center (ICRC) have combined ...
The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws LOS ANGELES--(BUSINESS WIRE)--Researchers at ...
Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most ...
A predictive model utilizing serum metabolic profiles was able to distinguish ovarian cancer from control samples with 93% accuracy, according to a new study. Machine learning–based classification ...
In A Nutshell A handheld breath sensor read eight chemicals and flagged lung cancer risk in a 67-person study. Accuracy was 85.71% using the device alone and 92.86% when paired with GC–MS in analysis.
A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...
"Skin cancer, particularly melanoma, is a disease in which early detection is critically important for determining survival rates," says Prof. Jeon. "Since melanoma is difficult to diagnose based ...
This predictive model built on readily acquired clinical data provides encouraging results for the detection of residual disease. External validation and prospective studies implementing the model in ...
The partnership will expedite the availability of Freenome's tests in markets outside the U.S, according to the company.